NMDA-receptor antagonists in neuropathic pain: experimental methods to clinical trials.
about
Methadone treatment of chronic non-malignant pain and opioid dependence--a long-term follow-upGuidelines in the management of diabetic nerve pain: clinical utility of pregabalin.Subanesthetic ketamine infusion therapy: a retrospective analysis of a novel therapeutic approach to complex regional pain syndrome.Effects and consequences of nerve injury on the electrical properties of sensory neurons.Neuropathic pain in children with cancer.Low dose ketamine: a therapeutic and research tool to explore N-methyl-D-aspartate (NMDA) receptor-mediated plasticity in pain pathways.Three patients and their drugs: A parallel case paper on paediatric opiate use and withdrawal.Analgesic effects of ketamine infusion therapy in korean patients with neuropathic pain: A 2-week, open-label, uncontrolled study.Treatment of central sensitization in patients with 'unexplained' chronic pain: what options do we have?Efficacy of outpatient ketamine infusions in refractory chronic pain syndromes: a 5-year retrospective analysis.An intricate relationship between pain and depression: clinical correlates, coactivation factors and therapeutic targets.Syntheses, analytical and pharmacological characterizations of the 'legal high' 4-[1-(3-methoxyphenyl)cyclohexyl]morpholine (3-MeO-PCMo) and analogues.Central sensitization in chronic low back pain: A narrative review.Assessment of the effect of dextromethorphan and ketamine on the acute nociceptive threshold and wind-up of the second pain response in healthy male volunteers.Two N-methyl-D-aspartate receptors in rat dorsal root ganglia with different subunit composition and localization.Safety, pharmacokinetics, and pharmacodynamics of CHF 3381, a novel N-methyl-D-aspartate antagonist, after single oral doses in healthy subjects.Influence of concomitant quinidine administration on dextromethorphan disposition in rats.Glutamate and tachykinin receptors in central sensitization of withdrawal reflexes in the decerebrated rabbit.Pharmacokinetics of dextromethorphan after single or multiple dosing in combination with quinidine in extensive and poor metabolizers.An observational study on the effect of S+-ketamine on chronic pain versus experimental acute pain in Complex Regional Pain Syndrome type 1 patients.Continuous brachial plexus blockade in combination with the NMDA receptor antagonist memantine prevents phantom pain in acute traumatic upper limb amputees.Low doses of dextromethorphan have a beneficial effect in the treatment of neuropathic pain.
P2860
Q28257915-98A67CC8-83F8-4FDA-B28B-E6D2C370DC58Q30537158-A1167527-7AD9-4CE9-A59E-E23E22B043A9Q34348231-CF661567-E67A-47BA-BB83-6114851DFF87Q35191517-E88E9F35-8A1F-44AA-BE06-C09CF5FB32B8Q35913796-2EC0D4A1-1662-4AFC-A092-65DF3152C6D1Q36860042-65D972ED-8601-4265-8F78-46523407341DQ37293855-D0C82E27-AA1A-4D3F-A55B-C21E260B775BQ37667211-0C1C28E1-AF73-4312-8115-E522E59FB1D0Q37831320-EEB6E29E-B930-4F0A-9F2C-78C4AD8DF181Q37937069-3D5B842D-2019-407F-8CDF-4979283B15FCQ38167857-299C6738-F816-40E7-B78D-AD2D5D3D5021Q38781226-1A3F2957-09B3-41BD-800D-A53BBD8E304CQ38803435-F9A69AFF-3BB5-4711-A924-BBD82993D519Q41761005-DB49BDDF-0994-4602-96DB-F848CADBC801Q43959884-D402D2FC-6AEB-4B33-BE32-3B8CC992B464Q44571965-8BD67E96-31D9-4526-87F0-DFAC6D8BE177Q44850827-D1DD3B07-78B4-489F-BCDB-D6FE531701C0Q44881021-2E0B4013-4620-4F47-AFB0-5D672077C6BCQ45040972-0AEAE3EE-5967-4037-AF2C-67A44879AA38Q45961975-9468F3E9-3C6C-43A7-8647-2FB78F454439Q48696301-E0ACFAEA-7893-46A1-81CA-2773BB3F2E4BQ50672736-68DECB95-CE0B-491D-A7AD-E7AC3694C79E
P2860
NMDA-receptor antagonists in neuropathic pain: experimental methods to clinical trials.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
NMDA-receptor antagonists in neuropathic pain: experimental methods to clinical trials.
@ast
NMDA-receptor antagonists in neuropathic pain: experimental methods to clinical trials.
@en
type
label
NMDA-receptor antagonists in neuropathic pain: experimental methods to clinical trials.
@ast
NMDA-receptor antagonists in neuropathic pain: experimental methods to clinical trials.
@en
prefLabel
NMDA-receptor antagonists in neuropathic pain: experimental methods to clinical trials.
@ast
NMDA-receptor antagonists in neuropathic pain: experimental methods to clinical trials.
@en
P1476
NMDA-receptor antagonists in neuropathic pain: experimental methods to clinical trials.
@en
P2093
P356
10.1016/S0885-3924(99)00125-6
P433
P577
2000-01-01T00:00:00Z